Clinical Trials
3 trialsNCT04983901 2026-04-06
PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00261807 2022-01-27
Daptomycin for the Treatment of Severe Necrotizing Soft-Tissue Infections
University of Maryland, Baltimore
Phase NA Completed
NCT00335478 2017-05-09
Daptomycin in Treating Neutropenia and Fever in Patients With Cancer
OHSU Knight Cancer Institute
Phase 2 Completed